Skip to main content

Month: August 2021

Veterinary Vaccines Market 2021 – 2028 | Is Set to Grow USD 16.13 Billion in 2028 at a CAGR of 6.0%

Top Players Covered in the Veterinary Vaccines Market Research Report are Elanco (Greenfield, U.S.), HIPRA (Girona, Spain), Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany), Virbac (Carros, France), MSD Animal Health (New Jersey, U.S.), Zoetis (Parsippany, U.S), Ceva (Libourne, France), NEOGEN CORPORATION (Michigan, U.S.), Hester Biosciences Limited (Ahmedabad, India) and Other Market Players Pune, India, Aug. 26, 2021 (GLOBE NEWSWIRE) — The global veterinary vaccines market size was USD 10.24 billion in 2020. The market is set to grow from USD 10.73 billion in 2021 and reach USD 16.13 billion in 2028 at a CAGR of 6.0% in the 2021-2028 period. This information is provided by Fortune Business Insights™ in its report titled, “Veterinary Vaccines Market, 2021-2028.” As per our researchers, the substantial growth...

Continue reading

Sonoco-Alcore to Increase Paperboard Prices in the EMEA Region

BRUSSELS, Belgium, Aug. 26, 2021 (GLOBE NEWSWIRE) — Sonoco-Alcore S.a.r.l. announced today that due to inflationary pressures it will raise prices by €50 / tonne on all recycled paperboard grades sold in the Company’s EMEA regions. The increase is in direct response to the continued escalation of its cost base and will be effective for all shipments made on or after the 1st September 2021. “Our business continues to experience unprecedented cost inflation across many elements of the business including energy, waste paper, chemicals, packaging and freight. Whilst we have made every effort to mitigate these price pressures, we now have no choice but to pass the increases onto the market. We will continue to monitor market trends over the next quarter and will react accordingly. At this point we cannot rule out further increases before...

Continue reading

TCR² Therapeutics Announces Renowned Translational Medicine Leader Priti Hegde Joins Its Board of Directors

CAMBRIDGE, Mass., Aug. 26, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced the appointment of Priti Hegde, Ph.D., to its Board of Directors. Dr. Hegde brings to TCR2 over 20 years of cancer genomics and immunology, clinical product development and early stage research experience in the biopharmaceutical industry, including an interdisciplinary focus on translational medicine. In connection with Dr. Hegde’s arrival, Patrick Baeuerle, Ph.D., will be stepping down from the Board of Directors effective August 24, 2021 but will continue to serve TCR2 in an advisory capacity. “As we continue to advance gavo-cel in clinical trials across multiple cancer indications and simultaneously innovate...

Continue reading

Burlington Stores, Inc. Reports Second Quarter 2021 Earnings

All Second Quarter 2021 comparisons are made versus the Second Quarter 2019On a GAAP basis, total sales increased 34%, net income was $103 million, and diluted EPS increased 19% to $1.50 Comparable store sales increased 19% On a non-GAAP basis, Adjusted EBIT was $183 million, an increase of 110 basis points as a percentage of sales On a non-GAAP basis, Adjusted EPS increased 43% to $1.94BURLINGTON, N.J., Aug. 26, 2021 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the second quarter ended July 31, 2021. Michael O’Sullivan, CEO, stated, “We are pleased with our second quarter results, which showed continued strong momentum in sales...

Continue reading

Titan Machinery Inc. Announces Results for Fiscal Second Quarter Ended July 31, 2021

– Revenue for Second Quarter of Fiscal 2022 Increased 24.4% to $377.6 million – – GAAP EPS for Second Quarter of Fiscal 2022 was $0.50 and Adjusted EPS was $0.57 – – Company Increases Fiscal 2022 Modeling Assumptions – WEST FARGO, N.D., Aug. 26, 2021 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, today reported financial results for the fiscal second quarter ended July 31, 2021. David Meyer, Titan Machinery’s Chairman and Chief Executive Officer, stated, “Equipment demand momentum continued through our second fiscal quarter with our equipment revenues increasing 35% versus prior year. The current environment is supported by our healthy inventory position and robust demand, along with continued strength...

Continue reading

Women’s Health Devices Market Size | Is Projected to Grow USD 62.61 Billion in 2028 at a CAGR of 8.4%

Key Prominent Players Covered in the Women’s Health Devices Market Research Report Are Coloplast A/S, Hologic Inc., Boston Scientific Corporation, ALLERGAN,BD, Hoffmann-La Roche Ltd, CooperSurgical Inc., Caldera Medical, Reckitt Benckiser Group PLC Pune, India, Aug. 26, 2021 (GLOBE NEWSWIRE) — The global women’s health devices market size was USD 34.23 billion in 2020. The market is projected to grow from USD 35.63 billion in 2021 to USD 62.61 billion in 2028 at a CAGR of 8.4% in the 2021-2028 period. This information is provided by Fortune Business Insights™ in its report titled, “Women’s Health Devices Market, 2021-2028.” According to our researchers, the upsurge in the spending towards women’s health is mainly owing to the mounting consciousness of female health concerns, coupled with the constant rise in the disposable incomes...

Continue reading

Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference

WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo 2021 Virtual Healthcare Conference on Thursday, September 9, 2021 at 12:40 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

Continue reading

Grocery Outlet Holding Corp. Announces Participation In The Goldman Sachs 28th Annual Global Retailing Conference

EMERYVILLE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”) today announced that the Company will be participating in a virtual fireside chat at the Goldman Sachs 28th Annual Global Retailing Conference on Thursday, September 9, 2021 at 12:50 PM ET. Attending for Grocery Outlet will be Eric Lindberg, Chief Executive Officer, RJ Sheedy, President, Charles Bracher, Chief Financial Officer and Arvind Bhatia, Vice President of Investor Relations. The audio portion of the presentation will be webcast live over the internet and can be accessed at https://investors.groceryoutlet.com/news-and-events/investor-calendar. An online archive will be available for a period of 30 days following the presentation. About Grocery Outlet: Based in Emeryville, California, Grocery...

Continue reading

Stereotactic Body Radiation Therapy Market Report 2021-2028 | Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast

Key Prominent Players Covered in the Stereotactic Body Radiation Therapy Market are Isoray Inc., Siemens, IBA Worldwide 2019, Medical Systems, Inc., Nordion Inc., Elekta AB, Mallinckrodt, BD, Mevion Medical Systems, Accuray Incorporated and Other key market players Pune, India, Aug. 26, 2021 (GLOBE NEWSWIRE) — The global stereotactic body radiation therapy market is expected to grow remarkably owing to the rising prevalence of various types of cancer. This information is published by Fortune Business Insights™, in an upcoming study, titled, “Stereotactic Body Radiation Therapy Market Size, Share and Global Trend By Type (Electron-Emitting High-Energy Linear Accelerators (Linac), Proton beam Therapy, Gamma Knife), By End User (Hospitals & Specialty Clinics, Cancer Radiotherapy Centres, Ambulatory Surgical Center, others) and...

Continue reading

Chindata Group Reports Second Quarter 2021 Unaudited Financial Results

Recent Financial and Operating HighlightsContinued to deliver solid financial performance. For the second quarter of 2021, revenue grew 64.2% year over year to RMB686.4 million (US$106.3 million). Net income was at a record high of RMB65.1 million (US$10.1 million) and stayed positive for two consecutive quarters, with a net income margin of 9.5%. Adjusted EBITDA increased 65.8% year over year to RMB338.5 million (US$52.4 million), with a margin of 49.3%. Cash generation remained healthy, with cash flow from operation at RMB285.8 million (US$44.3 million). 87MW new capacity under construction added, with deepened cooperation with existing and new customers. During the quarter, the Company added 3 new projects under-construction with a total capacity of 87MW, and an additional 66MW of capacity with indication of interest (“IOI”), and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.